Biophytis S.A. (BPTSY)
USD 1.94
(0.0%)
USD 1.94
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 13.18 Million EUR | -43.72% |
| 2022 | 23.42 Million EUR | -40.81% |
| 2021 | 39.57 Million EUR | 19.22% |
| 2020 | 33.19 Million EUR | 67.77% |
| 2019 | 19.78 Million EUR | -20.67% |
| 2018 | 24.94 Million USD | -19.95% |
| 2017 | 31.15 Million USD | 251.96% |
| 2016 | 8.85 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q2 | 15.94 Million EUR | 0.0% |
| 2023 FY | 13.18 Million EUR | -43.72% |
| 2023 Q4 | 13.18 Million EUR | 0.0% |
| 2022 Q2 | 35.38 Million USD | 0.0% |
| 2022 Q4 | 23.42 Million EUR | 0.0% |
| 2021 Q2 | 42.27 Million USD | 0.0% |
| 2021 Q4 | 41.15 Million USD | 0.0% |
| 2020 Q4 | 33.19 Million USD | 0.0% |
| 2020 Q2 | 21.12 Million USD | 0.0% |
| 2019 Q4 | 19.78 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Nuo Therapeutics, Inc. | 1.87 Million USD | -602.127% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -2542.099% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -4946.407% |
| Evofem Biosciences, Inc. | 10.55 Million USD | -24.93% |
| GB Sciences, Inc. | 103.44 Thousand USD | -12646.372% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | -47.333% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -73642.181% |
| Skye Bioscience, Inc. | 11.94 Million USD | -10.424% |
| Zenith Capital Corp. | 7410.00 USD | -177836.599% |
| Agentix Corp. | 261.39 Thousand USD | -4944.187% |
| Arch Therapeutics, Inc. | 1.95 Million USD | -573.331% |
| Biomind Labs Inc. | 73.81 Thousand USD | -17761.393% |
| ContraFect Corporation | 20.67 Million USD | 36.239% |
| CSL Limited | 38.02 Billion USD | 99.965% |
| CytoDyn Inc. | 11.13 Million USD | -18.401% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -1610.92% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | 52.816% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -2643.712% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -18120.275% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -3628.639% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | 89.874% |
| SQZ Biotechnologies Company | 107.18 Million USD | 87.699% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | -297.979% |
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | 66.059% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -820.727% |
| Mesoblast Limited | 667.9 Million USD | 98.026% |
| Marizyme, Inc. | 22.01 Million USD | 40.109% |
| Genus plc | 1.02 Billion USD | 98.719% |
| Pharming Group N.V. | 462.85 Million USD | 97.151% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -2002.887% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -3349.999% |
| IMV Inc. | 31.33 Million USD | 57.92% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | -218.018% |
| MultiCell Technologies, Inc. | 126.22 USD | -10446027.397% |
| ONE Bio Corp. | 70.08 Million USD | 81.187% |
| RVL Pharmaceuticals plc | 128.51 Million USD | 89.74% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | 62.52% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -810.044% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | 56.072% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | -380.098% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -1817.872% |
| Alpha Cognition Inc. | 2.45 Million USD | -437.691% |
| Enzolytics Inc. | 361.7 Million USD | 96.355% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 4.54 Billion USD | 99.71% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | 72.359% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -1961.28% |
| Genscript Biotech Corporation | 3.38 Billion USD | 99.611% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | -82.625% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -17168.384% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -3997.221% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -4944.728% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -1320.868% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -870.668% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -3277.626% |
| Adynxx, Inc. | - USD | -Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -1303.135% |
| Helix BioMedix, Inc. | 3.02 Million USD | -335.859% |
| EV Biologics, Inc. | 431.71 Thousand USD | -2954.129% |
| Q BioMed Inc. | 3.51 Million USD | -275.054% |
| Capstone Therapeutics Corp. | 52.7 Million USD | 74.981% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | 97.046% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| BioStem Technologies, Inc. | 14.56 Million USD | 9.445% |
| Curative Biotechnology, Inc. | 2.6 Million USD | -406.497% |
| HST Global, Inc. | 1526.00 USD | -863930.275% |
| Burzynski Research Institute, Inc. | 2310.00 USD | -570683.636% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -1234.569% |
| Halberd Corporation | 10.13 Thousand USD | -130046.106% |
| Resverlogix Corp. | 8.11 Million USD | -62.478% |
| Cell Source, Inc. | 195.17 Thousand USD | -6655.667% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -57777.626% |
| GeneThera, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 7.37 Million USD | -78.729% |
| Ember Therapeutics, Inc. | 184.00 USD | -7165716.304% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| NovAccess Global Inc. | 62.24 Thousand USD | -21081.567% |
| Kadimastem Ltd | 2.3 Million USD | -472.25% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -13683.729% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -22993.674% |
| LadRx Corporation | 2.3 Million USD | -471.307% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -3628.639% |
| Affymax, Inc. | 7.44 Million USD | -77.148% |
| Itoco Inc. | 1.4 Million USD | -841.745% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -12338.775% |
| Mobile Lads Corp. | 52.00 USD | -25355865.385% |
| International Stem Cell Corporation | 5.39 Million USD | -144.622% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| Bioxytran, Inc. | 137.63 Thousand USD | -9479.551% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -9122.157% |
| Qrons Inc. | 420.00 USD | -3139210.0% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -3320.517% |
| SYBLEU INC | 330.46 Thousand USD | -3889.827% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -2288.086% |
| Rebus Holdings, Inc. | 5000.00 USD | -263602.04% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -3120.419% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | 12.11% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | 20.471% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -16590.003% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -1424.859% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | -75.404% |
| Neutra Corp. | 2851.00 USD | -462372.887% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | 59.313% |
| PureTech Health plc | 693.97 Million USD | 98.1% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | -63.362% |
| IXICO plc | 15.84 Million USD | 16.781% |
| IntelGenx Technologies Corp. | 8.28 Million USD | -59.202% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 87.239% |
| CSL Limited | 38.02 Billion USD | 99.965% |
| Cellectis S.A. | 333.99 Million USD | 96.052% |